乔治临床( George Clinical ), a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The new offic […]
了解更多
OVERLAND PARK, KS, March 6, 2019 乔治临床( George Clinical ), a leading Asia-Pacific based clinical research organization (CRO) with global capabilities, today announced that Dr. Maria Ali has bee […]
了解更多[Sydney, Australia] 乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Coun […]
了解更多乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) […]
了解更多乔治临床( George Clinical ) welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke resea […]
了解更多乔治临床( George Clinical ) welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departu […]
了解更多SYDNEY, January 22, 2019 – 乔治临床( George Clinical ), headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief […]
了解更多乔治临床( George Clinical ), a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund […]
了解更多
In another encouraging step towards making China a leading destination for clinical drug trials, some critical developments were announced at The Executive Meeting of the State Council on the […]
了解更多
George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA. 乔治临床 […]
了解更多
